<SEC-DOCUMENT>0001213900-21-025416-index.html : 20210510
<SEC-HEADER>0001213900-21-025416.hdr.sgml : 20210510
<ACCEPTANCE-DATETIME>20210510172454
ACCESSION NUMBER:		0001213900-21-025416
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210504
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210510
DATE AS OF CHANGE:		20210510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aditx Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001726711
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823204328
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39336
		FILM NUMBER:		21908587

	BUSINESS ADDRESS:	
		STREET 1:		2569 WYANDOTTE, ST.
		STREET 2:		SUITE 101
		CITY:			MOUNTAIN
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		909-488-0844

	MAIL ADDRESS:	
		STREET 1:		2569 WYANDOTTE, ST.
		STREET 2:		SUITE 101
		CITY:			MOUNTAIN
		STATE:			CA
		ZIP:			94043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADiTx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20171229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea140542-8k_aditxtherap.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea140542-8k_aditxtherap.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea140542ex10-1_aditxtherap.htm
<DESCRIPTION>LEASE AGREEMENT, DATED AS OF MAY 4, 2021, BY AND BETWEEN LS BIOTECH EIGHT, LLC, AS LANDLORD, AND ADITX THERAPEUTICS, INC., AS TENANT
<TEXT>
Document 2 - file: ea140542ex10-1_aditxtherap.htm

</DOCUMENT>
</SEC-DOCUMENT>